26 June 2020
26 June 2020
Fullerton Health, the leading integrated healthcare platform in Asia Pacific, has won the Healthcare Asia Award for Primary Care Provider of the Year for the third consecutive year. Founded in 2010, Fullerton Health owns more than 500 healthcare facilities and manages an extensive global network of over 12,000 healthcare providers in Asia Pacific. Today, Fullerton Health has a regional presence across nine markets – Singapore, Philippines, Australia, Indonesia, China, Hong Kong SAR, Malaysia, Papua New Guinea, and New Zealand – and continues to deepen its regional reach in these markets.
Fullerton Health’s value proposition is the integration of healthcare service offerings with customised management and advisory capabilities, in line with its purpose to deliver affordable and accessible care for all in Asia Pacific. With over 6,500 employees, including over 1,100 healthcare professionals across the region, Fullerton Health covers the whole primary care journey from managed care and network management services, primary care, and, diagnostics, specialty and ancillary care.
With innovation embedded in the company’s DNA, Fullerton Health continues to strengthen its digital capabilities to boost user experience and steer cost-effective solutions towards a more patient-centric system. It has since worked alongside leading technology companies such as Health Catalyst and Microsoft drive its digital transformation.
The integrated healthcare services model allows Fullerton Health to offer cost-effective and customised digital solutions to its clients based on their specific requirements, with the aim to enhance workforce productivity by improving employees’ health and wellness while optimising corporate health expenditure. Fullerton Health offers clients and employees alike seamless access to services via mobile app and online portal – Fullerton Healthcare Network3 (FHN3) system. Drawing on the data and insights from FHN3, the company is better able to align to clients’ requirements to customise a range of solutions, focusing on preventive care such as chronic care management, vaccination and wellness programmes.
With the restrictive environment of COVID-19, it has also been the catalyst to accelerate the adoption of its own telemedicine platform via FHN3 mobile application by its clients, allowing their employees customised convenience and unrestricted access to healthcare.
Staying true to its purpose in these difficult times, Fullerton Health used its proprietary commercial technology for community benefit. The overwhelming amount of information and news surrounding COVID-19 and related developments makes it difficult for the general public to find and focus on information that is relevant to them. Hence Fullerton Health has launched a COVID-19 Symptom Checker on our LiveFuller mobile application in Singapore and also customised it for the region to provide relevant recommendations for each country, including selected local language options.
Fullerton Health is also dedicated to giving back to the communities where it operates. Incorporated in 2015, Fullerton Health Foundation (FHF) is committed to collaborating with charities, government entities and NGOs, to improve the lives of the underprivileged by making healthcare and education in Asia Pacific more affordable and accessible.
Its initiatives include Project Big Heart, which supplies free consultations and medication to elderly and needy Singaporeans. Over 2,000 residents in Singapore have benefitted from this programme, since its establishment in 2015.
It also has been active in TB screening since early 2018. Partnering with the Global Fund an international organisation based in Geneva, FHF has been involved in serving the underserved communities across some of the major provinces in Indonesia. Their initiatives have covered a total of 278,075 people across factories, city slums, prisons, boarding schools and rural villages in the area of TB screening.
In January 2020, Fullerton Health, together with the World Economic Forum, Stop TB Partnership, the Global Fund, Johnson & Johnson and Philips, launched the “Ending Workplace TB” initiative at the World Economic Forum in Davos. It is currently involved in rolling out the Workplace TB education and screening programme in partnership with Yayasan KNCV and supported by Stop TB Partnership, a UN organisation which aims to eliminate TB as a public health problem.